Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials


A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Arizona

Glendale : Arizona Center for Cancer Care Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Peoria : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Phoenix : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Phoenix : St. Joseph's Hospital and Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

View More »

Scottsdale :

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Scottsdale : Pinnacle Oncology Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Tucson : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

California

Bakersfield : Comprehensive Blood and Cancer Center Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Berkeley : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Concord : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Corona : Wilshire Oncology Medical Group Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Corona : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Long Beach : Long Beach Memorial Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Los Angeles :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Los Angeles : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Oceanside : North County Oncology Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Oxnard : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Rancho Mirage : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

San Francisco : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Santa Maria : Central Coast Medical Oncology Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Colorado

Englewood : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Connecticut

Hartford : St. Francis Hospital and Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

New Britain : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New Britain : The Hospital of Central Connecticut Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Norwalk : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Stamford : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Florida

Miami : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Orlando : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sarasota : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Sunrise : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

View More »

Tampa : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Georgia

Savannah : Memorial University Medical Center

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

View More »

Augusta : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Macon : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Illinois

Hinsdale : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hinsdale : Sudarshan K. Sharma, MD, LTD Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Joilet :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Indiana

Indianapolis : Indiana University Simon Cancer Center Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Indianapolis : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Lafayette :

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Iowa

Ames : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ames : McFarland Clinic Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Louisiana

Covington :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Maryland

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Baltimore : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Baltimore : Greater Baltimore Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Massachusetts

Boston : Massachusetts General Hospital

Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Michigan

Ann Arbor : St. Joseph Mercy Hospital Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Kalamazoo : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kalamazoo : West Michigan Cancer Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Minnesota

Rochester : Mayo Clinic

Accelerating Gastrointestinal Recovery

St. Louis Park : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

St. Louis Park : Park Nicollet Frauenshuh Cancer Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Mississippi

Jackson : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Jackson : University of Mississippi Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Jackson : St. Dominic-Jackson Memorial Hospital Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Missouri

St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

St Louis : Washington University School of Medicine

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Montana

Billings : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Nevada

Las Vegas : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Las Vegas : Women's Cancer Care Center of Nevada Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Reno : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New Jersey

Camden : Cooper Health System / Cooper Cancer Institute Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Hackensack : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Voorhees : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New Mexico

Albuquerque : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New York

New York : Biomedical Research Alliance of New York

Ovarian/Fallopian/Primary Peritoneal Cancer

View More »

Albany : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Albany : Women's Cancer Care Associates Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Bridgewater :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Brightwaters : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Brooklyn : SUNY Downstate Medical Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Buffalo :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

New York :

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

New York : Bellevue Hospital Center (NYU Langone Medical Center affiliate)

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

New York : New York University Clinical Cancer Center

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

New York : Columbia University Medical Center

Neoadjuvant Therapy for Ovarian Cancer

New York : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

North Carolina

Asheville : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Burlington : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Burlington : Alamance Regional Cancer Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Charlotte : Carolinas Medical Center/Blumenthal Cancer Center Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Charlotte : Carolinas Medical Center / Levine Cancer Institute Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

View More »

Concord : Carolinas Medical Center - Northeast Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Durham :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Durham : Duke Cancer Institute

BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer

Winston Salem : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ohio

Akron : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kettering : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Toledo : ProMedica Health System, Inc. Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Oklahoma

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Oklahoma City :

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Oklahoma City : University of Oklahoma

Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Oklahoma City : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Oklahoma City : Peggy and Charles Stephenson Cancer Center Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Tulsa : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tulsa : Tulsa Cancer Institute Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Oregon

Bend : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Pennsylvania

Abington :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Abington : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Abington : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Abington : Abington Memorial Hospital; Hanjani Institute for Gynecologic Oncology Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Bethlehem : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Philadelphia :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Philadelphia : Fox Chase Cancer Center

MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

Philadelphia : Fox Chase Cancer Center

Neoadjuvant Therapy for Ovarian Cancer

Philadelphia : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

Pittsburgh : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Pittsburgh : Western Pennsylvania Hospital Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Rhode Island

Providence : Women & Infants' Hospital

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

Providence : Women and Infants Hospital of Rhode Island Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

South Carolina

Greenville : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Greenville : Bon Secours St. Francis Hospital Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

South Dakota

Sioux Falls : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Sioux Falls : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tennessee

Chattanooga : Chattanooga GYN Oncology Updated

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Chattanooga : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Texas

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Austin : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Bedford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Bedford : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Dallas : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Ft. Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Galveston : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Houston : UT MD Anderson Cancer Center

First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer

Houston : The University of Texas MD Anderson Cancer Center

MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

San Antonio : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Utah

Ogden : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Vermont

Burlington : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Virginia

Annandale : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Annandale : Mid Atlantic Pelvic Surgery Associates Updated

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Charlottesville : University of Virginia

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Charlottesville : University of Virginia

Neoadjuvant Therapy for Ovarian Cancer

Norfolk : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Woodbridge : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Washington

Seattle : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Wenatchee : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Wisconsin

Green Bay : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Green Bay : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Milwaukee : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Oshkosh : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sheboygan : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Wausau : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

West Allis : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Australia

Auchenflower : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Footscray : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

New Lambton Heights : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Parkville : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Wahroonga : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Austria

Graz : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Graz : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Innsbruck : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Innsbruck : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Linz : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

View More »

Linz : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Salzburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Wien : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Wien : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Belarus

Gomel : Gomel Regional Clincial Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Minsk : Alexandrov National Cancer Center of Belarus

Study of Paclitaxel in Patients With Ovarian Cancer

Minsk : Minsk City Clinical Oncology Hospital

Study of Paclitaxel in Patients With Ovarian Cancer

Vitebsk : Vitebsk Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Belgium

Bonheiden : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Brasschaat : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Charleroi : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Charleroi : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Duffel : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Edegem : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Edegem : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Gent : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Gent : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hasselt : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ieper : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Kortrijk : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Leuven : Department of gyneacology, Campus Gasthuisberg

Study of Paclitaxel in Patients With Ovarian Cancer

Leuven : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Leuven : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Liège : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Liège : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Libramont : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Libramont : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Namur : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Namur : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Oostende : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sint-Niklaas : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Turnhout : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Wilrijk : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Yvoir : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Brazil

Barretos : Hospital de Câncer de Barretos Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Belo Horizonte : Oxion Hospital Dia Oncologia Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Curitiba : Hospital Erasto Gaertner Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Florianópolis : CEPON - Centro de Pesquisas Oncológicas de Santa Catarina Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Jaú : Fundação Amaral Carvalho Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

View More »

Porto Alegre : Hospital de Clínicas de Porto Alegre Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Rio de Janeiro : INCA - Instituto Nacional de Câncer Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Salvador : Núcleo de Oncologia da Bahia Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

São Paulo : Hospital Israelita Albert Einstein Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

São Paulo : Hospital Santa Marcelina Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

São Paulo : Instituto do Câncer do Estado de São Paulo "Octávio Frias de Oliveira" Updated

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Bulgaria

Shumen : Regional Oncology Dispensary

Study of Paclitaxel in Patients With Ovarian Cancer

Sofia : Hospital for a Active Treatment, Tsaritsa Yoanna

Study of Paclitaxel in Patients With Ovarian Cancer

Stara Zagora : Regional Oncology Dispensary

Study of Paclitaxel in Patients With Ovarian Cancer

Canada

Calgary : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Edmonton : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Halifax : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hamilton :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Kingston : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

London : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Montreal : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Quebec : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sault Ste. Marie : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Toronto :

A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Toronto : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Croatia

Rijeka : Klinički Bolnički Centar Rijeka

Study of Paclitaxel in Patients With Ovarian Cancer

Split : Klinički Bolnički Centar Split

Study of Paclitaxel in Patients With Ovarian Cancer

Czech Republic

Olomouc : Onkologická klinika, Fakultní nemocnice Královské Vinohrady

Study of Paclitaxel in Patients With Ovarian Cancer

Plzen : Onkologické a radioterapeutické oddělení, Fakultní nemocnice Plzeň

Study of Paclitaxel in Patients With Ovarian Cancer

Prague : Radioterapeutická a onkologická klinika, Fakultní nemocnice Královské Vinohrady

Study of Paclitaxel in Patients With Ovarian Cancer

Prague : Ústav radiační onkologie, Fakultní nemocnice Na Bulovce

Study of Paclitaxel in Patients With Ovarian Cancer

Denmark

Herlev : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Herlev : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Herning : Onkologisk Afdelning, Herning Sygehus

Study of Paclitaxel in Patients With Ovarian Cancer

København : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

København Ø : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Roskilde : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Finland

Kuopio : Kuopion Yliopistollinen Sairaala, Naisten Klinikka

Study of Paclitaxel in Patients With Ovarian Cancer

Turku : Turun Yliopistollinen Keskussairaala, Naisten Klinikka,

Study of Paclitaxel in Patients With Ovarian Cancer

Germany

Aalen : Ostalbklinikum

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Berlin : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Düsseldorf : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Dresden : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Erlangen : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Essen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Essen : University hospital, Dept. of gynecology & obstetrics

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Essen : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Essen : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Esslingen : Klinikum Esslingen

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Frankfurt : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Frankfurt am Main : Klinikum der JWG Universität Frankfurt

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Frankfurt am Main : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Freiburg : Universitätsklinikum Freiburg, Frauenklinik

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Freiburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Hamburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hannover : Medizinische Hochschule

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Hannover : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Kiel : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Konstanz : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ludwigsburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

München : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Mainz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Offenburg : St. Josefsklinik

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Paderborn : St. Vincenz-Krankenhaus

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Ravensburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Rostock : Klinikum Südstadt

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Rostock : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Rostock : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Stuttgart : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tübingen : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ulm : Universitätsklinikum, Universitätsfrauenklinik

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Ulm : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Wiesbaden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 for Recurrent Ovarian Cancer

Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Wolfsburg : Klinikum der Stadt Wolfsburg

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Greece

Athens : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Thessaloniki : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hong Kong

Hong Kong : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Hong Kong : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kowloon : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New Territories : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

New Territories : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Hungary

Budapest : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Debercen : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Kaposvár : Kaposi Mór Megyei Kórház, Onkológiai Tanszék

Study of Paclitaxel in Patients With Ovarian Cancer

Miskolc : B.-A.-Z. Megyei Kórház és Egyetemi Oktató Kórház, Észak-Kelet Magyarországi Regionális Klinikai Farmakológiai Központ

Study of Paclitaxel in Patients With Ovarian Cancer

Miskolc : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

View More »

Nyíregyháza : Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktató Kórháza, Onkoradiológia

Study of Paclitaxel in Patients With Ovarian Cancer

Szeged : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Veszprém : Veszprém Megyei Csolnoky Ferenc Kórház-Rendelőintézet ZRT

Study of Paclitaxel in Patients With Ovarian Cancer

Zalaegerszeg : Zala Megyei Kórház, Onkológia

Study of Paclitaxel in Patients With Ovarian Cancer

Zalaegerszeg : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Italy

Avellino : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Aviano PN : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Bologna : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Brescia : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Campobasso : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

View More »

Genova : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Milano : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Milano : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Napoli : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Napoli : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Novara : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Palermo : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Pisa : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Roma : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Roma : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Torino : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Japan

Fukuoka-shi : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kashiwa : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kitaadachi-gun : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kure-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kurume-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Morioka-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Nagoya-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sapporo-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Suntou-gun : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Tokyo : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Yonago-city : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Korea, Republic of

Goyang-si, Gyeonggi-do : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Seoul : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Latvia

Riga : Latvian Oncology Center of Riga Easter Hospital Ltd

Study of Paclitaxel in Patients With Ovarian Cancer

Lithuania

Kaunas : Kaunas Medical University Hospital, Oncology Clinic

Study of Paclitaxel in Patients With Ovarian Cancer

Vilnius : Institute of Oncology, Vilnius University

Study of Paclitaxel in Patients With Ovarian Cancer

Netherlands

Deventer : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Leiden : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Nijmegen : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Rotterdam : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

New Zealand

Tauranga : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Romania

Cluj Napoca : Cluj CF University Hospital

Study of Paclitaxel in Patients With Ovarian Cancer

Constanta : Constanta Clinical County Hospital

Study of Paclitaxel in Patients With Ovarian Cancer

Craiova : MEDITECH SRL, ORIZONT Polyclinic

Study of Paclitaxel in Patients With Ovarian Cancer

Oradea : County Clinical Emergency Hospital Oradea

Study of Paclitaxel in Patients With Ovarian Cancer

Russian Federation

Arkhangelsk : State Medical Institution, Arkhankelsk Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Barnaul : State Medical Institution, Altai Regional Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Chelyabinsk : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Ekaterinburg : State Budget-funded Medical Institution of Sverdlovsk Region "Sverdlovsk Regional Oncology Center"

Study of Paclitaxel in Patients With Ovarian Cancer

View More »

Ivanovo : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Kazan : Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Kirov : State Treatment and Prevention Institution, Kirov Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Krasnodar : State Medical Institution "Clinical Oncology Center #1" under the Ministry of Health of Krasnodar Region

Study of Paclitaxel in Patients With Ovarian Cancer

Krasnodar : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Magnitogorsk : State Medical Institution, Regional Oncology Center #2, Surgery department

Study of Paclitaxel in Patients With Ovarian Cancer

Moscow : N.N. Blokhin Cancere Research Center under the Russian Academy of Medical Sciences

Study of Paclitaxel in Patients With Ovarian Cancer

Moscow : Federal State Institution, Central Clinical Hospital with Outpatient Unit under the Russian Presidential Administration

Study of Paclitaxel in Patients With Ovarian Cancer

Moscow : State Institution, Moscow City Oncology Hospital #62

Study of Paclitaxel in Patients With Ovarian Cancer

Moscow : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Nizhniy Novgorod : Federal State Institution "Privolzhskiy District Medical Center of Federal Bio-medical Agency"

Study of Paclitaxel in Patients With Ovarian Cancer

Obninsk : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Omsk : State Medical Institution of the Omsk Region, Clincial Oncology center

Study of Paclitaxel in Patients With Ovarian Cancer

Orenburg, : State Medical Institution "Orenburg Regional Clinical Oncology Center"

Study of Paclitaxel in Patients With Ovarian Cancer

Penza : State Medicinal Institution, Reginal oncology center

Study of Paclitaxel in Patients With Ovarian Cancer

Petrozavodsk : State Medical Institution "Republic Oncology Center"

Study of Paclitaxel in Patients With Ovarian Cancer

Pyatigorsk : Pyatigorsk Affiliate of State Medical Institution, Stavropol Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Saint Petersburg : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Saint-Petersburg, : State Medical Institution "Leningrad Regional Oncology Center"

Study of Paclitaxel in Patients With Ovarian Cancer

Samara : Samara Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Sochi : State Medical Institution, Oncology Center #2 under the Krasnodar Region Healthcare Department

Study of Paclitaxel in Patients With Ovarian Cancer

St Petersburg : St Petersburg State Medical Institution, City clinical oncology center

Study of Paclitaxel in Patients With Ovarian Cancer

St Petersburg : Federal State Medical Institution, N.N. Petrov Research Institute of Oncology under the Federal Agency for High-Tech Medical Care of the Russian Federation, Oncogynecology Department

Study of Paclitaxel in Patients With Ovarian Cancer

Stavropol, : State Medical Institution "Stavropol Regional Clinical Oncology Center"

Study of Paclitaxel in Patients With Ovarian Cancer

Tambov : State Medical Institution, Tambov Regional Oncology Center #2

Study of Paclitaxel in Patients With Ovarian Cancer

Ufa : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Voronezh : State Medical Institution, Voronezh Regional Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Voronezh : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Yaroslavl : State Medical Institution of the Yaroslavl, Region Clinical Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Serbia

Belgrade : Institut za onkologiju i radiologiju Srbije, Klinika za medikalnu onkologiju

Study of Paclitaxel in Patients With Ovarian Cancer

Kragujevac : Klinički Bolnički Centar Kragujevac, Centar za onkologiju i radioterapiju

Study of Paclitaxel in Patients With Ovarian Cancer

Niš : Klinički Centar Niš, Klinika za onkologiju

Study of Paclitaxel in Patients With Ovarian Cancer

Sremska Kamenica : Institut za onkologiju Vojvodine, Klinika za operativnu onkologiju

Study of Paclitaxel in Patients With Ovarian Cancer

Singapore

Singapore : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Slovakia

Banska Bysterica : Onkologicke oddelenie, FNsP F. D. Roosevelta

Study of Paclitaxel in Patients With Ovarian Cancer

Bratilslava : Interne oddelenie, Narodny onkologicky ustav

Study of Paclitaxel in Patients With Ovarian Cancer

Bratislava : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Kosice : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Presov : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

View More »

Simferopol : Crimean Republicann Oncology Dispensary

Study of Paclitaxel in Patients With Ovarian Cancer

Spain

Badalona : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Barcelona : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Lleida : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Madrid : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Oviedo : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

View More »

Palma de Mallorca : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Valencia : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Zaragoza : Research Site Updated

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Sweden

Göteborg : Divisionen för Onkologi , Sahlgrenska Universitetssjukhuset

Study of Paclitaxel in Patients With Ovarian Cancer

Linköping : Onkologikliniken, Universitetssjukhuset Linköping

Study of Paclitaxel in Patients With Ovarian Cancer

Lund : Onkologiska Kliniken, Universitetssjukhuset Lund

Study of Paclitaxel in Patients With Ovarian Cancer

Örebro : Kliniken för Gynekologisk Onkologi, Regionsjukhuset

Study of Paclitaxel in Patients With Ovarian Cancer

Umeå : Gyn-Onkologiska kliniken, Norrlands universitetssjukhus

Study of Paclitaxel in Patients With Ovarian Cancer

Taiwan

Tainan : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Taipei : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Ukraine

Cherkassy : Cherkassy Regional Oncological Centre

Study of Paclitaxel in Patients With Ovarian Cancer

Chernivtsy : Cherkassy Regional Oncological Centre

Study of Paclitaxel in Patients With Ovarian Cancer

Dnepropetrovsk : KZ, City Clinical Hospital #19 City oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Dnipropetrovsk : Multi-profile clinical hospital#4

Study of Paclitaxel in Patients With Ovarian Cancer

Donetsk : Donetsk Regional Antitumor Center

Study of Paclitaxel in Patients With Ovarian Cancer

View More »

Ivano-Frankivsk, 76018 : Ivano-Frankivsk Regional Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Kharkiv : Kharkiv Regional Clinical Oncology

Study of Paclitaxel in Patients With Ovarian Cancer

Kharkiv : "S.P. Grygoryev Institute of Medical Radiology of the Academy of Medical Science of Ukraine

Study of Paclitaxel in Patients With Ovarian Cancer

Kherson : Kherson Reginal Oncological Center

Study of Paclitaxel in Patients With Ovarian Cancer

Kiev : Kiev City Oncology center

Study of Paclitaxel in Patients With Ovarian Cancer

Kiev : DU, National Institute of Cancer, Department of Oncogynecology

Study of Paclitaxel in Patients With Ovarian Cancer

Kyiv : Kyiv Regional Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Lugansk : Lugansk Regional Oncology Center

Study of Paclitaxel in Patients With Ovarian Cancer

Odessa : Odessa City Oncological Center

Study of Paclitaxel in Patients With Ovarian Cancer

Sumy : Sumy Regional Onclolgy Center

Study of Paclitaxel in Patients With Ovarian Cancer

Ternopil : Ternopil Regional Oncology Hospital

Study of Paclitaxel in Patients With Ovarian Cancer

United Kingdom

London : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Manchester : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Northwood : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Nottingham : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2

Poole : Research Site

TRINOVA-2: Trebananib in Ovarian Cancer-2